Filtros de búsqueda

Lista de obras de

A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced Cancer

artículo científico publicado en 2015

A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III PIK3CA-Mutant ER-Positive and HER2-Negative Breast Cancer.

artículo científico publicado en 2017

A Transcriptionally Definable Subgroup of Triple-Negative Breast and Ovarian Cancer Samples Shows Sensitivity to HSP90 Inhibition

artículo científico publicado en 2019

A comprehensive analysis of breast cancer microbiota and host gene expression.

artículo científico publicado en 2017

A hot flash on tamoxifen metabolism

artículo científico publicado en 2003

A multidisciplinary approach to the management of breast cancer, part 1: prevention and diagnosis

artículo científico publicado en 2007

A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations

artículo científico publicado en 2007

A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors

artículo científico publicado en 2017

A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors

scientific article published on 31 August 2018

A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer ⬇️

artículo científico publicado el 19 de abril de 2013

A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2.

artículo científico publicado en 2015

A two-gene expression ratio of homeobox 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen

artículo científico publicado en 2006

ATR Inhibition Is a Promising Radiosensitizing Strategy for Triple-Negative Breast Cancer

Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression

artículo científico publicado en 2015

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer

article

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

artículo científico publicado en 2019

Anastrozole has an association between degree of estrogen suppression and outcomes in early breast cancer and is a ligand for estrogen receptor α

artículo científico publicado en 2020

Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype

scientific article published on 18 September 2013

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer

scientific article published on 19 May 2020

Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen

artículo científico publicado en 2009

Author Correction: Regulation of sister chromatid cohesion by nuclear PD-L1

artículo científico publicado en 2020

Automated discovery of drug treatment patterns for endocrine therapy of breast cancer within an electronic medical record ⬇️

artículo científico publicado el 1 de diciembre de 2011

Baseline estrogen levels in postmenopausal women participating in the MAP.3 breast cancer chemoprevention trial

artículo científico publicado en 2020

Breast Cancer Version 2.2015.

artículo científico publicado en 2015

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 April 2020

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2018

Breast cancer chemoprevention pharmacogenomics: Deep sequencing and functional genomics of the ZNF423 and CTSO genes

artículo científico publicado en 2017

Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score

artículo científico publicado en 2011

CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.

artículo científico publicado en 2017

CRM1 inhibitor anti-tumor activity is enhanced with salicylates by S-phase arrest and impaired DNA-damage repair

artículo científico publicado en 2020

CYP2D6 and Tamoxifen: Awaiting the Denouement ⬇️

artículo científico publicado el 31 de octubre de 2011

CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations

artículo científico publicado en 2013

CYP2D6 genotype and tamoxifen response

artículo científico publicado en 2005

CYP2D6 genotype and tamoxifen: considerations for proper nonprospective studies

artículo científico publicado en 2014

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. ⬇️

artículo científico publicado en 2012

Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity

artículo científico publicado en 2018

Case-Based Review and Clinical Guidance on the Use of Genomic Assays for Early-Stage Breast Cancer: Breast Cancer Therapy Expert Group (BCTEG)

scientific article published on 08 January 2020

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical Trial

scientific article published on 30 September 2019

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy

artículo científico publicado en 2018

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

scientific article published on 03 June 2019

Clinical trial designs for prospective validation of biomarkers

artículo científico publicado en 2005

Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy

artículo científico publicado en 2016

Colonic polyposis and neoplasia in Cowden syndrome.

artículo científico publicado en 2011

Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized Sprague-Dawley rats

artículo científico publicado en 2014

Comparison of 99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy

artículo científico publicado en 2019

Concordance between predicted HLA type using next generation sequencing data generated for non-HLA purposes and clinical HLA type

artículo científico publicado en 2020

Coprescription of tamoxifen and medications that inhibit CYP2D6.

artículo científico publicado en 2010

Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance

artículo científico publicado en 2008

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

artículo científico publicado en 2018

Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer

scientific article published on 01 October 2019

Development, characterization, and applications of a novel estrogen receptor beta monoclonal antibody

scientific article published on February 2012

Developments in combination chemotherapy for colorectal cancer

artículo científico publicado en 2004

Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer.

artículo científico publicado en 2018

ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer

artículo científico publicado en 2017

ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis

article published in the Proceedings of the National Academy of Sciences of the United States of America

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer

artículo científico publicado en 2014

Early discontinuation of tamoxifen: a lesson for oncologists

artículo científico publicado en 2007

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

artículo científico publicado en 2017

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).

artículo científico publicado en 2018

Endocrine therapy in 2009: consideration of the tumor and the host.

artículo científico publicado en 2009

Endoxifen's molecular mechanisms of action are concentration dependent and different than that of other anti-estrogens

artículo científico publicado en 2013

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

artículo científico publicado en 2017

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

artículo científico publicado en 2022

Estrogen receptor-beta sensitizes breast cancer cells to the anti-estrogenic actions of endoxifen

artículo científico publicado en 2011

Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation

artículo científico publicado en 2016

Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole

artículo científico publicado en 2014

Evaluation of CYP2D6 and efficacy of tamoxifen and raloxifene in women treated for breast cancer chemoprevention: results from the NSABP P1 and P2 clinical trials

artículo científico publicado en 2011

Evaluation of CYP2D6 enzyme activity using a 13C-dextromethorphan breath test in women receiving adjuvant tamoxifen

artículo científico publicado en 2015

Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer

artículo científico publicado en 2020

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

artículo científico publicado en 2015

Factors Influencing Use of Hormone Therapy for Ductal Carcinoma In Situ: A National Cancer Database Study

artículo científico

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer

artículo científico publicado en 2017

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

artículo científico publicado en 2020

Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial

artículo científico publicado en 2012

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)

artículo científico publicado en 2015

Gene-Expression–Based Predictors for Breast Cancer

article

Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy

artículo científico publicado en 2016

Genetic polymorphisms of CYP2D6*10 and CYP2C19*2, *3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen

artículo científico publicado en 2010

Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors

artículo científico publicado en 2010

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab

artículo científico publicado en 2018

HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data

scholarly article by Saurabh Baheti published in July 2018

Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series

scientific article published on 01 May 2006

Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer?

artículo científico publicado en 2017

Health-Related Quality of Life in MONARCH 3: Abemaciclib Plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer

artículo científico publicado en 2020

Image-guided ablation of painful metastatic bone tumors: a new and effective approach to a difficult problem.

artículo científico publicado en 2005

Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 interpretation in breast cancer

artículo científico publicado en 2009

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

artículo científico publicado en 2017

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

artículo científico publicado en 2022

Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology

article

Landscape of neoadjuvant therapy for breast cancer

artículo científico publicado en 2015

Loss of heterozygosity at the CYP2D6 locus in breast cancer: implications for germline pharmacogenetic studies.

artículo científico publicado en 2014

Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

artículo científico publicado en 2017

MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

artículo científico publicado en 2019

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer

artículo científico publicado en 2017

MRI Radiomics for Assessment of Molecular Subtype, Pathological Complete Response, and Residual Cancer Burden in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

artículo científico publicado en 2020

Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3

scientific article published on 21 September 2020

Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities

artículo científico publicado en 2022

Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts

artículo científico publicado en 2013

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

artículo científico publicado en 2019

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy

artículo científico publicado en 2008

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006 ⬇️

artículo científico publicado el 8 de abril de 2013

Multidisciplinary Management of Breast Cancer With Extensive Regional Nodal Involvement

scientific article published on 22 May 2020

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

artículo científico publicado en 2015

NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

artículo científico publicado en 2017

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

artículo científico publicado en 2019

NOTCH3 expression is linked to breast cancer seeding and distant metastasis

scientific article published on 04 September 2018

NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer

artículo científico publicado en 2017

Neratinib Efficacy and Circulating Tumor DNA Detection of HER2 Mutations in HER2 Nonamplified Metastatic Breast Cancer.

artículo científico publicado en 2017

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma.

artículo científico publicado en 2017

Oncophenotypic review and clinical correlates of phosphatase and tensin homolog on chromosome 10 hamartoma tumor syndrome

artículo científico publicado en 2010

Optimized immunohistochemical detection of estrogen receptor beta using two validated monoclonal antibodies confirms its expression in normal and malignant breast tissues

scientific article published on 30 September 2019

Oxaliplatin plus oral fluoropyrimidines in colorectal cancer

artículo científico publicado en 2004

PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient

scientific article published on 01 December 2018

Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation

artículo científico publicado en 2002

Painful metastases involving bone: percutaneous image-guided cryoablation--prospective trial interim analysis.

artículo científico publicado en 2006

Palliation of Painful Metastatic Disease Involving Bone With Imaging-Guided Treatment: Comparison of Patients' Immediate Response to Radiofrequency Ablation and Cryoablation ⬇️

artículo científico publicado el 1 de agosto de 2011

Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx

scientific article published on 09 April 2020

Pemetrexed and oxaliplatin for metastatic colorectal cancer: results of a phase I Mayo Cancer Center Research Consortium trial, MC0248.

artículo científico publicado en 2007

Percutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.

artículo científico publicado en 2012

Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study

artículo científico publicado en 2004

Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

artículo científico publicado en 2020

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

artículo científico publicado en 2005

Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action

scientific article published on 23 July 2020

Pharmacokinetics of endoxifen and tamoxifen in female mice: implications for comparative in vivo activity studies

artículo científico publicado en 2014

Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients

artículo científico publicado en 2015

Phase I and pharmacokinetic study of two different schedules of oxaliplatin, irinotecan, Fluorouracil, and leucovorin in patients with solid tumors

artículo científico publicado en 2003

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer

artículo científico publicado en 2005

Phase I trial to evaluate the addition of alisertib to fulvestrant in women with endocrine-resistant, ER+ metastatic breast cancer.

artículo científico publicado en 2017

Phase II trial of oxaliplatin/irinotecan/5-fluorouracil/leucovorin for metastatic colorectal cancer

artículo científico publicado en 2007

Predicting Nodal Positivity in Women 70 Years of Age and Older with Hormone Receptor-Positive Breast Cancer to Aid Incorporation of a Society of Surgical Oncology Choosing Wisely Guideline into Clinical Practice

artículo científico publicado en 2017

Pregnancy-associated plasma protein-A expression in human breast cancer

artículo científico publicado en 2014

Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model

artículo científico publicado en 2004

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

artículo científico publicado en 2018

Providing Balance in ASCO Clinical Practice Guidelines: CYP2D6 Genotyping and Tamoxifen Efficacy

scientific article published on 01 November 2016

Quantitative Analysis of Tyrosine Phosphorylation from FFPE Tissues Reveals Patient-Specific Signaling Networks

artículo científico publicado en 2021

Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial

artículo científico publicado en 2020

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.

artículo científico publicado en 2006

Re: Concordance between CYP2D6 genotypes obtained from tumor-derived and germline DNA.

artículo científico publicado en 2014

Regulation of sister chromatid cohesion by nuclear PD-L1

artículo científico publicado en 2020

Reply to A.-S. Dieudonné et al and J.M. Rae et al.

artículo científico publicado en 2013

SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway

artículo científico publicado en 2017

SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen

artículo científico publicado en 2011

Selective Estrogen Receptor Modulators and Pharmacogenomic Variation in ZNF423 Regulation of BRCA1 Expression: Individualized Breast Cancer Prevention ⬇️

artículo científico publicado el 13 de junio de 2013

Serum thymidine kinase 1 activity as a pharmacodynamic marker of cyclin-dependent kinase 4/6 inhibition in patients with early-stage breast cancer receiving neoadjuvant palbociclib.

artículo científico publicado en 2017

Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.

artículo científico publicado en 2012

Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer

artículo científico publicado en 2020

Skeletal and Uterotrophic Effects of Endoxifen in Female Rats

artículo científico publicado en 2017

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall

artículo científico publicado en 2019

Synergistic interactions between aminoflavone, paclitaxel and camptothecin in human breast cancer cells

artículo científico publicado en 2009

TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer

artículo científico publicado en 2014

TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer

scientific article published on 29 October 2019

TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression

artículo científico publicado en 2013

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

artículo científico publicado en 2018

Tamoxifen Metabolism and Breast Cancer Recurrence: A Question Unanswered by CYPTAM

artículo científico publicado en 2019

Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response

artículo científico publicado en 2007

Tamoxifen use in postmenopausal breast cancer: CYP2D6 matters

artículo científico publicado en 2012

Targeted Therapy for BRCA2 Deficient Tumors

artículo científico publicado en 2005

The Hsp90 chaperone complex as a novel target for cancer therapy

artículo científico publicado en 2003

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

artículo científico publicado en 2022

The effects of a novel hormonal breast cancer therapy, endoxifen, on the mouse skeleton

artículo científico publicado en 2014

The emerging role of CDK4/6i in HER2-positive breast cancer

scientific article published on 27 November 2019

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

artículo científico publicado en 2006

The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer

article published in 2019

The path to a better biomarker: Application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice

scientific article published on 04 March 2020

The tamoxifen metabolite, endoxifen, is a potent antiestrogen that targets estrogen receptor alpha for degradation in breast cancer cells

artículo científico publicado en 2009

Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging

artículo científico publicado en 2009

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

artículo científico publicado en 2017

Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.

artículo científico publicado en 2017

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway

artículo científico publicado en 2018

UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine

artículo científico publicado en 2013

Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study

artículo científico publicado en 2017

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2015

Using Size and Grade to Identify Women Aged ≥ 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity : Letter to Editor Reply to "Sized influences nodal status in women aged ≥ 70 with endocrine responsive breast cancer" by

artículo científico publicado en 2017

Variation in anastrozole metabolism and pharmacodynamics in women with early breast cancer

artículo científico publicado en 2010

Window-of-Opportunity Trials in the Preoperative Setting: Insights Into Drug Development for Estrogen Receptor-Positive Breast Cancer

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda